Aethlon Medical announces 1-for-5 reverse stock split effective July 31, 2026

AETHLON MEDICAL INC

Reverse stock split approved by board; no stockholder vote required under Nevada law.
Effective 10:00 a.m. ET on July 31, 2026; split-adjusted trading begins August 4, 2026 under symbol AEMD.
Pre-split shares: 3,249,569; post-split approx 649,914; authorized shares reduced from 100M to 20M.
No fractional shares issued; rounding up to whole share; CUSIP changes to 00808Y703.
Purpose: dilution management and continued compliance with Nasdaq minimum bid price rule.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.